2030 年镓-68 市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00029992
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

 

[研究报告] 镓-68 市场预测可以帮助该市场的利益相关者概述其增长战略。预计该市场将从 2022 年的 7.8236 亿美元增长到 2030 年的 10.7034 亿美元;预计 2022-2030 年的复合年增长率为 4.0%。

 

市场洞察和分析师观点:

镓-68 是一种用于医疗诊断程序的正电子发射放射性同位素。它由锗-68/镓-68 (68Ge/68Ga) 发生器产生,半衰期为 68 分钟。前列腺癌和神经内分泌肿瘤患病率的增加以及核成像技术使用的激增是推动镓-68 市场增长的主要因素。然而,镓-68 的保质期短阻碍了市场的增长。此外,放射性示踪剂在癌症诊断中的使用预计将在未来几年带来新的镓-68 市场趋势。

 

增长动力:

 

前列腺癌和神经内分泌肿瘤患病率上升推动镓-68市场增长

前列腺癌和神经内分泌肿瘤的高发性导致对正电子发射断层扫描 (PET) 诊断程序的需求增加。根据梅奥医学教育和研究基金会 (MFMER) 的说法,神经内分泌肿瘤是由神经内分泌细胞的恶性生长发展而来的。镓-68 (Ga-68) 用于放射性诊断剂的放射性标记,以通过 PET 定位成人和儿童的生长抑素受体阳性神经内分泌肿瘤。根据英国癌症研究中心的数据,英国每年有 4,000 多人被诊断出患有神经内分泌肿瘤。约 50% 的神经内分泌肿瘤始于消化系统(胃、小肠和大肠、胰腺和直肠),约 20% 始于肺部。根据美国临床肿瘤学会 (ASCO) 的数据,美国每年有近 12,000 人被诊断患有神经内分泌肿瘤,估计有 171,000 人患有此病。

Ga-68 主要用于检测人体内的癌细胞。例如,Ga-68 PSMA-11 PET 扫描成像剂被广泛用于检测前列腺癌细胞。根据世界癌症研究基金会 (WCRF) 国际组织的数据,2020 年报告了超过 140 万例前列腺癌新病例。同样,根据国际癌症研究机构 (IARC) 的数据,前列腺癌病例数预计将从 2022 年的约 147 万例增加到 2030 年的约 183 万例,到 2050 年将增加到约 288 万例。因此,前列腺癌和神经内分泌肿瘤需要使用基于 Ga-68 的 PET 进行准确的医学诊断,这有助于改善肿瘤检测并促进有效的治疗计划。因此,这些疾病的患病率不断上升,扩大了镓-68 的市场规模。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

镓-68市场:

Gallium-68 Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

报告细分和范围:

镓-68 市场分析考虑了以下几个部分:应用和最终用户。根据应用,市场细分为肿瘤学、神经病学、心脏病学等。肿瘤学领域在 2022 年占据了镓-68 最大的市场份额,预计在预测期内将实现最高的复合年增长率。肿瘤学领域的市场细分为前列腺癌、神经内分泌肿瘤等。

根据最终用户,市场分为医院、诊断和影像中心以及其他。医院部门在 2022 年占据了最大的镓-68 市场份额。此外,预计同一部门在预测期内的复合年增长率最高。

 

区域分析:

镓-68 市场报告的地理范围包括北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022 年,北美占据了最大的市场份额。混合成像等技术的进步、用于诊断和治疗的新型放射性药物的引入以及基于示踪原理的分子成像技术的开发极大地促进了美国核医学的进步。获得先进的医疗基础设施、前列腺癌发病率和患病率的上升以及主要参与者的产品创新进一步促进了北美镓-68 市场的扩张。根据国际癌症研究机构 (IARC) 的数据,美国癌症患者数量预计将从 2020 年的 228 万例增加到 2040 年的 312 万例。因此,预计癌症病例的增加将刺激对核成像的需求,这有利于镓-68 市场的发展。

 

行业发展和未来机遇:

以下列出了镓-68 市场主要参与者的一些战略发展(根据公司新闻稿):

  • 2023 年 12 月,Ariceum Therapeutics 获得了其镓-68 (Ga-68) 放射性药物生产套件的美国和加拿大专利。该知识产权由 Theragnostics Ltd 开发,该公司于 2023 年被 Ariceum 收购。此前,Ga-68 放射性药物的生产涉及多步骤方法,这限制了可随时生产的患者剂量数量。Theragnostics 的 Ga-68 技术平台只需一个简单的步骤即可在单个小瓶中生产多剂量的 Ga-68 HBED-PSMA-11。
  • 2023 年 3 月,Telix Pharmaceuticals 的补充新药申请 (sNDA) Illuccix(Ga-68 戈泽托肽注射制剂套件)获得 FDA 批准,用于筛查转移性前列腺癌患者,建议对这些患者进行镥-177 PSMA 靶向治疗。
  • 2022 年 10 月,Telix 获得加拿大卫生部批准,将 Illuccix(Ga-68 戈泽托肽注射制剂套件)用于中高风险前列腺癌的分期和重新分期,以及复发性前列腺癌的肿瘤组织定位。Illuccix 经 Ga-68 放射性标记后,建议与 PET 一起使用,以检测男性前列腺癌患者的 PSMA 阳性病变。
  • 2021 年 9 月,Eckert & Ziegler Radiopharma GmbH 向美国 FDA 提交了 GalliaPharm 的药物主文件 (DMF) 修正案,从而将其镓-68 发生器产品组合扩展到美国市场。该公司计划提供其专利的 Ge-68/Ga-68 发生器,其尺寸高达 100 mCi,保质期为 12 个月或 700 次洗脱。GalliaPharm 的 Ga-68 用于制备PET诊断成像药物。

 

 

镓-68市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响镓-68 市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的镓-68 市场细分和地理位置。

Gallium-68 Market
  • 获取镓-68市场的区域特定数据

镓-68市场报告范围

报告属性细节
2022 年市场规模7.8236亿美元
2030 年市场规模10.7034亿美元
全球复合年增长率(2022 - 2030 年)4.0%
史料2020-2022
预测期2022-2030
涵盖的领域按应用
  • 肿瘤学
  • 神经病学
  • 心脏病学
按最终用户
  • 医院
  • 诊断和影像中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 诺华公司
  • Telix Pharmaceuticals(美国)有限公司
  • 艾尔艾利特公司
  • ITM 医用同位素有限公司
  • 埃克特和齐格勒放射制药有限公司
  • ARTMS 公司
  • IBA 放射性药物解决方案
  • 康德乐
  • 俄罗斯国家原子能公司

 

镓-68 市场参与者密度:了解其对业务动态的影响

镓-68 市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在镓-68市场运营的主要公司有:

  1. 诺华公司
  2. Telix Pharmaceuticals(美国)有限公司
  3. 艾尔艾利特公司
  4. ITM 医用同位素有限公司
  5. 埃克特和齐格勒放射制药有限公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Gallium-68 Market

 

  • 获取镓-68 市场顶级关键参与者概览

 

竞争格局和重点公司:

诺华公司、Telix Pharmaceuticals (US) Inc、IRE-ELiT SA、ITM Medical Isotopes GmbH、Eckert & Ziegler Radiopharma GmbH、ARTMS Inc、IBA Radiopharma Solutions、Cardinal Health、Rosatom 和 Evergreen Theragnostics Inc 是镓-68 市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地理覆盖范围,以满足全球日益增长的消费者需求。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
gallium-68-market-report-deliverables-img1
gallium-68-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


Which end user segment dominates the gallium-68 market?

The market, by end user, is categorized into hospitals, diagnostic and imaging centers, and others. The hospitals segment held the largest gallium-68 market share in 2022 and it is anticipated to register the highest CAGR during the forecast period.

What are the growth estimates for the gallium-68 market till 2030?

The gallium-68 market is expected to be valued at US$ 1.070.34 million in 2030.

Which application segment dominates the gallium-68 market?

By application, the market is segmented into oncology, neurology, cardiology, and others. The oncology segment held the largest gallium-68 market share in 2022 and it is anticipated to register the highest CAGR during the forecast period. Based on oncology the market is subsegmented into prostate cancer, neuroendocrine tumors, and others.

What was the estimated gallium-68 market size in 2022?

The gallium-68 market was valued at US$ 782.36 million in 2022.

Who are the major players in the gallium-68 market?

The gallium-68 market majorly consists of the players, including Novartis AG, Telix Pharmaceuticals (US) Inc, IRE-ELiT SA, ITM Medical Isotopes GmbH, Eckert & Ziegler Radiopharma GmbH, ARTMS Inc, IBA Radiopharma Solutions, Cardinal Health, Rosatom, and Evergreen Theragnostics Inc.

What is gallium-68?

Gallium-68 is a positron-emitting radioisotope used in medical diagnostic procedures produced from germanium-68/gallium-68 (68Ge/68Ga) generator. Gallium-68 has good positron-emitting properties and a half-life of 68 min.

What factors drive the gallium-68 market?

Factors such as increase in the prevalence of prostate cancer and neuroendocrine tumors and the increasing use of nuclear imaging techniques propel the gallium-68 market growth.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Gallium-68 Market

  1. Novartis AG
  2. Telix Pharmaceuticals (US) Inc
  3. IRE-ELiT SA
  4. ITM Medical Isotopes GmbH
  5. Eckert & Ziegler Radiopharma GmbH
  6. ARTMS Inc
  7. IBA Radiopharma Solutions
  8. Cardinal Health
  9. Rosatom
  10. Evergreen Theragnostics Inc
gallium-68-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.